E1	Procedure:T1 Name:T2
E3	Observation:T3 Name:T4 Numeric-Filter:E20
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E9	Condition:T9 Name:T10 Temporality:E22
E11	Condition:T11 Name:T12
E17	Condition:T17 Name:T18
E20	Eq-Comparison:T34 Operator:T21 Value:T28 Unit:T39 Unit2:T40
E21	Eq-Comparison:T35 Operator:T22 Value:T29 Unit:T45 Per:T46
E22	Eq-Comparison:T36 Temporal-Unit:T27 Value:T33 Temporal-Period:T23
E2	Condition:T37 Name:T38
E4	Study:T41 
E10	Observation:T44 Minimum-Count:E16 Name:T43
E12	Study:T47 
E16	Eq-Comparison:T49 Operator:T50
E23	Drug:T52 Name:T53 Temporality:E25
E24	Negation:T54 Negates:E23
E25	Eq-Comparison:T55 Temporal-Period:T56
E13	Condition:T13 Name:T14
E26	Observation:T57 Name:T58
E27	Observation:T59 Name:T60
E28	Condition:T61 Name:T62
E29	Condition:T63 
E31	Study:T65 Stability:T66
E32	Assertion:T67 Asserted:T66
E33	Study:T68 
E34	Study:T69 Study-Of:E19
E19	Condition:T19 Name:T20
E35	Procedure:T70 Temporality:E36
E36	Eq-Comparison:T71 Temporal-Unit:T24 Temporal-Period:T72 Value:T30
E39	Study:T75 
E41	Eq-Comparison:T77 Temporal-Unit:T25 Temporal-Period:T78 Value:T31
E42	Eq-Comparison:T79 Temporal-Period:T80
E45	Study:T83 Study-Of:E46
E46	Drug:T84 
E47	Eq-Comparison:T85 Temporal-Unit:T26 Temporal-Period:T86 Value:T32
E15	Condition:T15 Name:T16
E50	Drug:T89 Name:T90
E51	Procedure:T91 Temporality:E52
E52	Eq-Comparison:T92 Temporal-Period:T93
E53	Study:T94 Study-Of:E54
E54	Drug:T95 
E55	Allergy:T96 Name:E54
E8	Observation:T97 Name:T98 Minimum-Count:E16
E56	Procedure:T99 
E57	Negation:T100 Negates:E56
T1	Procedure 62 80	neonatal screening
T2	Procedure-Name 62 80	neonatal screening
T3	Observation 99 115	Phenylalaninemia
T4	Observation-Name 99 115	Phenylalaninemia
T5	Condition 974 989	Phenylketonuria
T6	Condition-Name 974 989	Phenylketonuria
T7	Condition 853 872	pre-conception diet
T8	Condition-Name 853 872	pre-conception diet
T9	Condition 818 827	Pregnancy
T10	Condition-Name 818 827	Pregnancy
T11	Condition 874 883	pregnancy
T12	Condition-Name 874 883	pregnancy
T17	Condition 337 340	PKU
T18	Condition-Name 337 340	PKU
T21	Eq-Operator 116 117	≥
T22	Eq-Operator 203 204	≥
T24	Eq-Temporal-Unit 661 665	days
T25	Eq-Temporal-Unit 714 720	months
T26	Eq-Temporal-Unit 806 812	months
T27	Eq-Temporal-Unit 845 851	months
T28	Eq-Value 118 121	900
T29	Eq-Value 204 207	900
T30	Eq-Value 659 660	7
T31	Eq-Value 712 713	6
T32	Eq-Value 804 805	6
T33	Eq-Value 843 844	6
T34	Eq-Comparison 116 129	≥ 900μmol / L
T35	Eq-Comparison 203 216	≥900 μmol / L
T36	Eq-Comparison 836 851	within 6 months
T37	Condition 25 40	Phenylketonuric
T38	Condition-Name 25 40	Phenylketonuric
T39	Eq-Unit 121 125	μmol
T40	Eq-Unit 128 129	L
T41	Study 157 166	screening
T44	Observation 186 202	blotting results
T45	Eq-Unit 208 212	μmol
T46	Eq-Unit 215 216	L
T47	Study 250 259	screening
T49	Eq-Comparison 220 227	several
T50	Eq-Operator 220 227	several
T52	Drug 307 328	amino acid supplement
T53	Drug-Name 307 328	amino acid supplement
T54	Negation 292 295	not
T55	Eq-Comparison 296 302	taking
T56	Eq-Temporal-Period 296 302	taking
T13	Condition 405 415	court bail
T14	Condition-Name 405 415	court bail
T57	Observation 417 428	curatorship
T58	Observation-Name 417 428	curatorship
T59	Observation 430 442	guardianship
T60	Observation-Name 430 442	guardianship
T61	Condition 461 481	concomitant diseases
T62	Condition-Name 461 481	concomitant diseases
T63	Condition 484 494	conditions
T65	Study 519 524	study
T66	Stability 504 514	compromise
T67	Assertion 500 503	may
T68	Study 587 601	clinical trial
T69	Study 605 610	trial
T19	Condition 623 626	PKU
T20	Condition-Name 623 626	PKU
T70	Procedure 636 646	treatments
T71	Eq-Comparison 654 665	last 7 days
T72	Eq-Temporal-Period 654 658	last
T75	Study 675 684	inclusion
T77	Eq-Comparison 707 720	next 6 months
T78	Eq-Temporal-Period 707 711	next
T79	Eq-Comparison 688 695	planned
T80	Eq-Temporal-Period 688 695	planned
T83	Study 761 766	study
T84	Drug 772 787	health products
T85	Eq-Comparison 799 812	next 6 months
T86	Eq-Temporal-Period 799 803	next
T23	Eq-Temporal-Period 836 842	within
T15	Condition 887 900	breastfeeding
T16	Condition-Name 887 900	breastfeeding
T89	Drug 1016 1019	BH4
T90	Drug-Name 1016 1019	BH4
T91	Procedure 1001 1010	treatment
T92	Eq-Comparison 990 1000	undergoing
T93	Eq-Temporal-Period 990 1000	undergoing
T94	Study 1054 1059	study
T95	Drug 1040 1047	product
T96	Allergy 1025 1032	Allergy
T43	Observation-Name 186 202	blotting results
T97	Observation 228 233	blots
T98	Observation-Name 228 233	blots
T99	Procedure 273 282	Untreated
T100	Negation 273 282	Untreated
A1	Eq-Operator-Value T21 GTEQ
A2	Eq-Operator-Value T22 GTEQ
A4	Eq-Temporal-Unit-Value T24 day
A5	Eq-Temporal-Unit-Value T25 month
A6	Eq-Temporal-Unit-Value T26 month
A7	Eq-Temporal-Unit-Value T27 month
A10	Eq-Operator-Value T50 GT
A11	Eq-Temporal-Period-Value T56 present
A12	Stability-Value T66 change
A13	Assertion-Type-Value E32 possible
A14	Eq-Temporal-Period-Value T72 past
A16	Eq-Temporal-Period-Value T78 future
A17	Eq-Temporal-Period-Value T80 future
A19	Eq-Temporal-Period-Value T86 future
A3	Eq-Temporal-Period-Value T23 past
A21	Eq-Temporal-Period-Value T93 present
A22	Observation-Type-Value E10 lab
A23	Observation-Type-Value E8 lab
R1	Found-By Arg1:E2 Arg2:E1
R2	Treatment-For Arg1:E23 Arg2:E17
R3	Caused-By Arg1:T66 Arg2:E29
R4	Treatment-For Arg1:E35 Arg2:E19
R5	Using Arg1:E51 Arg2:E50
R6	Treatment-For Arg1:E51 Arg2:E5
R7	If-Then Arg1:E8 Arg2:E10
R8	Equivalent-To Arg1:E24 Arg2:E57
R9	During Arg1:E3 Arg2:E4
R10	During Arg1:E8 Arg2:E12
R11	Or Arg1:E3 Arg2:E10
R12	Or Arg1:E28 Arg2:E29
R13	Or Arg1:E33 Arg2:E34
R14	Or Arg1:E19 Arg2:E35
R15	Before Arg1:E36 Arg2:E39
R16	During Arg1:E42 Arg2:E41
R17	Or Arg1:E39 Arg2:E42
R18	During Arg1:E45 Arg2:E47
R19	Or Arg1:E11 Arg2:E15
R20	Or Arg1:E7 Arg2:E11
R21	Or Arg1:E13 Arg2:E26
R22	Or Arg1:E26 Arg2:E27
